Non-Current Assets
Investments
Edwards Lifesciences Investments increased by 2.5% to $285.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.8%, from $277.90M to $285.60M. Over 5 years (FY 2020 to FY 2025), Investments shows a downward trend with a -19.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
Growth in this category often signals strong cash flow generation and a strategy to build long-term financial reserves, whereas a decline may indicate divestment or the use of reserves for acquisitions.
Detailed definition
This represents the aggregate value of financial assets, such as debt and equity securities, that the company intends to...
Peer comparison
Highly significant for insurance companies; peers often disclose this as part of their investment portfolio.
Metric ID:
non_current_assets_long_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.01B | $1.28B | $1.83B | $1.62B | $1.49B | $1.38B | $1.24B | $1.07B | $856.20M | $704.60M | $583.90M | $455.60M | $353.30M | $319.60M | $307.90M | $277.90M | $298.50M | $274.70M | $278.60M | $285.60M |
| QoQ Change | — | +26.4% | +43.1% | -11.5% | -8.2% | -7.4% | -10.3% | -13.9% | -19.7% | -17.7% | -17.1% | -22.0% | -22.5% | -9.5% | -3.7% | -9.7% | +7.4% | -8.0% | +1.4% | +2.5% |
| YoY Change | — | — | — | — | +47.0% | +7.7% | -32.5% | -34.3% | -42.6% | -49.0% | -52.9% | -57.3% | -58.7% | -54.6% | -47.3% | -39.0% | -15.5% | -14.0% | -9.5% | +2.8% |
Range$274.70M – $1.83B
CAGR-23.4%
Avg YoY Growth-28.1%
Median YoY Growth-36.7%
Current Streak2 quarters growth
Investments at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's investments?
- Edwards Lifesciences (EW) reported investments of $285.60M in Q1 2026.
- How has Edwards Lifesciences's investments changed year-over-year?
- Edwards Lifesciences's investments increased by 2.8% year-over-year, from $277.90M to $285.60M.
- What is the long-term trend for Edwards Lifesciences's investments?
- Over 5 years (2020 to 2025), Edwards Lifesciences's investments has grown at a -19.1% compound annual growth rate (CAGR), from $801.60M to $278.60M.
- What does investments mean?
- Financial assets held by the company for more than one year to generate long-term returns.